Berlin’s Diagnostisch Therapeutisches Zentrum (DTZ) has become the first in the world to treat a patient using Elekta Evo, an ...

There's new hope for people battling advanced bladder cancer who do not respond to first-line therapy, researchers report.

A Mayo Clinic Comprehensive Cancer Center researcher will share findings from a late-breaking abstract at the 2024 Society of ...

An experimental immunotherapy drug is a potentially effective treatment for patients with bladder cancer who no longer ...

There may be an effective new treatment for people with bladder cancer that doesn't respond to a frontline therapy.

AstraZeneca's Imfinzi gains FDA Priority Review for bladder cancer. Key trial data shows improved survival and progression ...

About Bladder Cancer More than 83,000 people are estimated to be diagnosed with bladder cancer in 2024. NMIBC is the most common form of bladder cancer, representing approximately 75% of newly ...

Breast, bladder, and pancreatic cancers are increasingly being treated with a broad range of therapies before a patient undergoes surgery, and cancer stage at diagnosis continues to be a leading ...

LUGPA annual meeting, Gautam Jayram, MD, reviewed important developments therapeutics and diagnosis and staging.

(UroToday.com) The 2024 Society of Urologic Oncology (SUO) annual meeting held in Dallas was host to the Bladder Cancer ...

with many remaining cancer-free beyond two years." The clinic went on to add that "most participants did not require bladder removal surgery, and the treatment was well tolerated with minimal ...